Analysis | Metabolite Name | Measured Value | Units | stress | treatment |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 165860 | Peak area | Y | +Lacto |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 176949 | Peak area | Y | None |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 178108 | Peak area | N | None |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 180210 | Peak area | Y | +Lacto |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 190211 | Peak area | Y | +Lacto |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 192642 | Peak area | Y | +Lacto |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 193022 | Peak area | Y | +Lacto |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 197085 | Peak area | Y | None |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 218678 | Peak area | Y | None |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 225001 | Peak area | Y | None |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 234477 | Peak area | Y | None |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 244995 | Peak area | N | None |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 276377 | Peak area | N | None |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 281702 | Peak area | N | None |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M-H)- | 376623 | Peak area | N | None |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 150870 | Peak area | Y | None |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 170037 | Peak area | Y | +Lacto |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 183481 | Peak area | Y | +Lacto |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 196518 | Peak area | Y | None |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 246126 | Peak area | N | None |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 323240 | Peak area | Y | None |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 330833 | Peak area | Y | +Lacto |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 336822 | Peak area | N | None |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 349585 | Peak area | Y | None |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 392076 | Peak area | Y | +Lacto |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 401878 | Peak area | N | None |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 424957 | Peak area | N | None |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | 523247 | Peak area | Y | +Lacto |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | Peak area | N | None | |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+H)+ | Peak area | Y | None | |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ | 118508 | Peak area | Y | None |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ | 147263 | Peak area | Y | +Lacto |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ | 163889 | Peak area | N | None |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ | Peak area | N | None | |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ | Peak area | Y | +Lacto | |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (CAS# 4042-36-8); (M+NA)+ | Peak area | Y | None |